Frontlight ResearchEarly access
Graves' disease trials in France
2 of 4 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 3WithdrawnA Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.
- Where
- Angers, Bron, Nantes, Paris
- Age
- 18 years and over
- People
- 230 worldwide
- Run by
- argenx
See details and how to joinNCT07596849 · EU 2025-523333-26-00 - No phaseNot yet taking people in FranceProspective Evaluation of OptiThyDose
- Where
- Paris
- Age
- Up to 18 years
- People
- 150 worldwide
- Run by
- University Children's Hospital Basel
See details and how to joinNCT06864351